ApprovalTrail

Approval · Notice of Compliance 2056 · 1999

SOLU-CROM: Notice of Compliance 2056

Issued February 22, 1999

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2056
Date
February 22, 1999
Company
Sabex Inc.Boucherville, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Antiallergic agent
Canadian reference product
OPTICROM (Fisons Corporation Ltd.)

Products in this notice

BrandDINStatus today
SOLU-CROM02239657Cancelled Post Market

Medicinal ingredients